menu
    • menu

    Company profile for GH Research

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases. In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy...
    GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases. In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy volunteer study and is currently being investigated in patients with Treatment-Resistant Depression. We believe our lead product GH001 has the potential to offer ultra-rapid and deep remissions in depression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GH ResearchIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    28 Baggot Street Lower, Dublin 2
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ghres.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ghresearch_ltd

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GH Research Reports Phase 2B Results For Mebufotenin In JAMA
    GH Research Reports Phase 2B Results For Mebufotenin In JAMA

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262385/0/en/GH-Research-Announces-Publication-of-Phase-2b-Results-for-Mebufotenin-GH001-in-JAMA-Psychiatry-and-Reports-New-Finding-of-Severity-Independent-Efficacy-in-TRD.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    GH Research: Full-Year 2025 Financial Results & Update
    GH Research: Full-Year 2025 Financial Results & Update

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250011/0/en/GH-Research-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Psychedelic Biotechs Advance CNS Treatments To Phase 3
    Psychedelic Biotechs Advance CNS Treatments To Phase 3

    27 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/psychedelic-biotechs-push-toward-phase-3-five-companies-advancing-cns-treatments-302699781.html

    PR NEWSWIRE
    27 Feb 2026
    Share Share
    FDA Lifts Hold on GH Research's GH001 for 2026 Phase 3 Trial
    FDA Lifts Hold on GH Research's GH001 for 2026 Phase 3 Trial

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212617/0/en/GH-Research-Announces-FDA-Lifts-Clinical-Hold-on-GH001-Clearing-Path-for-Global-Phase-3-Initiation-in-2026.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    GH Research To Announce IND Status For GH001
    GH Research To Announce IND Status For GH001

    02 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/02/3212274/0/en/GH-Research-to-Announce-IND-Status-for-GH001.html

    GLOBENEWSWIRE
    02 Jan 2026
    Share Share
    GH Research Presents Novel Therapies At 2025 ECNP Congress
    GH Research Presents Novel Therapies At 2025 ECNP Congress

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164013/0/en/GH-Research-Announces-Novel-Therapies-Symposium-Presentation-and-Posters-at-the-2025-ECNP-Congress.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search